Goal
Destabilize and disperse dental plaque biofilms to improve oral health and reduce cavities and gum disease.
Problem
Dental plaque biofilm contributes to cavities, gingivitis, periodontitis and associated healthcare costs.
Concept Summary
L-Arginine, a naturally occurring amino acid, interferes with bacterial co-aggregation and cell-cell signaling in multi-species oral biofilms, leading to reduced biofilm mass and enhanced penetration of antimicrobial agents such as cetylpyridinium chloride.
Principles
- Biofilm disruption
- Inhibition of bacterial co-aggregation
- Alteration of cell-cell signaling
- Concentration-dependent architectural changes
Scientific Domains
Materials
- L-Arginine monohydrochloride (LAHCl)
- Cetylpyridinium chloride (CPC)
Mechanisms of Action
- Inhibits bacterial coaggregation
- Alters bacterial metabolism
- Reduces extracellular polymeric substance (EPS) cohesion
- Promotes cell detachment from biofilm
Applications
- Oral healthcare products (toothpaste, mouthwash)
- Dental plaque control
- Medical device coating to prevent biofilm formation
Claimed Performance
Biofilm biovolume reduced up to two orders of magnitude when developed in saliva containing 100-500 mM L-Arginine; enhanced killing by CPC when combined with 500 mM L-Arginine.
Experimental Evidence
Laboratory microplate and microfluidic studies showed concentration-dependent reduction of multi-species oral biofilm mass and altered species composition; addition of L-Arginine increased CPC penetration and killing.
Limitations
- Exact molecular mechanism not fully elucidated
- Clinical efficacy pending human trials
- Potential taste or sensory effects at high concentrations
